The National Institutes of Health has awarded Oklahoma Medical Research Foundation scientist Magdalena Bieniasz, Ph.D., a ,000 grant to study promising ovarian cancer treatments.

The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $450,000 to research promising new ovarian cancer treatments.
OMRF scientist Magdalena Bieniasz, Ph.D., received the two-year grant to test combinations of drugs that may be more effective than current treatments for aggressive forms of ovarian cancer.
“There is a receptor protein that signals tumor cells to multiply faster and survive better,” said Bieniasz, who joined OMRF in 2016 from the Huntsman Cancer Institute in Utah. “We are studying drugs that could inhibit this signal.”
The presence of this receptor signal is one reason ovarian cancer often develops resistance to traditional therapies. After chemotherapy treatment, this signal promotes the growth of any cancer cells that weren’t stopped, producing a new tumor resistant to the previous medicine. (story continues below)

CMS 5 star Quality Rating
Great opportunity to work with us with excellent benefits, including great employer matching 401K,
Tuition Reimbursement, Christmas bonus and the opportunity for quarterly bonuses!
Leadership Opportunities:
· System CNO
· HR Director
South Campus:
· Med-Surg – FT $7,500 SIGNING BONUS
· RN Med-Surg Nights – FT $10,000 SIGNING BONUS
· RN Circulator – FT $10,000 SIGNING BONUS
· RN Endoscopy – FT
· RN Employee Health – FT
· RN Pre-Admission Testing – FT $3,000 SIGNING BONUS
· RN Quality Improvement Specialist – FT
· RN Pain – FT $3,000 SIGNING BONUS
· RN Pain/GI – PRN
· RN Pre-Admission Testing – PRN
· RN Med-Surg – PRN
North Campus:
· RN Med-Surg Nights – FT $10,000 SIGNING BONUS
· RN Circulator – FT $10,000 SIGNING BONUS
· RN Pre Op Phase II Recovery – FT $3,000 SIGNING BONUS
· RN Pre-Admission Testing Days – FT $3,000 SIGNING BONUS
· RN Pre-Admission Testing – PRN
· RN Med-Surg Nights – PRN
Northwest Surgical Hospital:
· RN Med-Surg Days – FT $7,500 SIGNING BONUS
· RN Pre-Op – PRN
· RN Med-Surg – PRN
Visit our career site for a current list of openings:
Community Hospital/Northwest Surgical Hospital complies with applicable
Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex.
Community Hospital/Northwest Surgical Hospital is a facility in which physicians have an ownership or investment interest.
The list of physician owners or investors is available to you upon request.

In an effort to slow or prevent this resistance, Bieniasz’s lab team plans to pair the compound blocking receptor signaling with a chemotherapy-type drug.
“We know that to achieve the strongest response, there has to be a combination,” Bieniasz said. “Two drugs combined may be better than the sum of each by itself.”
These drug combinations will be tested on cell models that represent tumors of patients at the University of Oklahoma Health Stephenson Cancer Center. OMRF scientists will use a targeted approach to treat the models, applying different drug combinations based on cancer type and stage.
“In targeted therapy, drugs are matched to specific tumors that have specific features,” said Bieniasz. “We characterize the samples so we know which tumor would be a good candidate for each treatment.”
Bieniasz noted this project will focus not only on what works, but why. Understanding the mechanism of the receptor signaling inhibition will help set up future studies for more effective treatments.
“The signaling protein is present in nearly half of ovarian cancer patients, and each one of those patients could benefit from this,” Bieniasz said.
The grant, No. R21 CA264573-01, is funded by the National Cancer Institute, a part of the NIH.